Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Adjusted fees for applications to European Medicines Agency from 1 April 2013 25 Februar 2013NewsCorporateMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 February 2013 22 Februar 2013NewsHuman Public consultation opens on standard paediatric investigation plans for two types of cancer in children 22 Februar 2013NewsHumanPaediatrics SME office: outcomes of seven years of active support to small and medium-size businesses 20 Februar 2013NewsCorporateSME Committee for paediatric medicinal products - towards more and better information on the use of medicines for children 18 Februar 2013NewsHumanPaediatrics Committee for Veterinary Medicinal Products - focus on reducing the risk of antimicrobial resistance and strengthening quality assurance 15 Februar 2013NewsVeterinary Committee for Orphan Medicinal Products – strengthened interactions with patients and international partners 14 Februar 2013NewsHumanRare diseases Committee for Advanced Therapies – focus on incentives for SMEs and strengthened interaction with stakeholders 13 Februar 2013NewsHumanAdvanced therapiesSMEInnovation Herbal medicines – strengthening assessment methodology and improved communication for the public 12 Februar 2013NewsHerbal The PROTECT project on pharmacovigilance achieves key objectives 12 Februar 2013NewsCorporate 1 … 234 235 236 237 238 Page 238 of 384 239 240 241 242 … 384
Adjusted fees for applications to European Medicines Agency from 1 April 2013 25 Februar 2013NewsCorporateMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 February 2013 22 Februar 2013NewsHuman
Public consultation opens on standard paediatric investigation plans for two types of cancer in children 22 Februar 2013NewsHumanPaediatrics
SME office: outcomes of seven years of active support to small and medium-size businesses 20 Februar 2013NewsCorporateSME
Committee for paediatric medicinal products - towards more and better information on the use of medicines for children 18 Februar 2013NewsHumanPaediatrics
Committee for Veterinary Medicinal Products - focus on reducing the risk of antimicrobial resistance and strengthening quality assurance 15 Februar 2013NewsVeterinary
Committee for Orphan Medicinal Products – strengthened interactions with patients and international partners 14 Februar 2013NewsHumanRare diseases
Committee for Advanced Therapies – focus on incentives for SMEs and strengthened interaction with stakeholders 13 Februar 2013NewsHumanAdvanced therapiesSMEInnovation
Herbal medicines – strengthening assessment methodology and improved communication for the public 12 Februar 2013NewsHerbal